Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
BMC Microbiol ; 20(1): 213, 2020 07 20.
Article de Anglais | MEDLINE | ID: mdl-32689948

RÉSUMÉ

BACKGROUND: Staphylococcus aureus is a leading cause of broad-spectrum infections both in the community and within healthcare settings. Methicillin-resistant Staphylococcus aureus (MRSA) has become a global public health issue. The aim of this study was to examine the clinical and molecular characteristics of Staphylococcus aureus isolates and to define the population structure and distribution of major MRSA clones isolated in a tertiary-care hospital in Mexico. RESULTS: From April 2017 to April 2018, 191 Staphylococcus aureus isolates were collected. The frequency of MRSA was 26.7%; these strains exhibited resistance to clindamycin (84.3%), erythromycin (86.2%), levofloxacin (80.3%), and ciprofloxacin (86.3%). The majority of MRSA strains harbored the SCCmec type II (76.4%) and t895 (56.8%) and t9364 (11.7%) were the most common spa types in both hospital-associated MRSA and community-associated MRSA isolates. ST5-MRSA-II-t895 (New York /Japan clone) and ST1011-MRSA-II-t9364 (New York /Japan-Mexican Variant clone) were the most frequently identified clones. Furthermore, different lineages of Clonal Complexes 5 (85.4%) and 8 (8.3%) were predominantly identified in this study. CONCLUSION: Our study provides valuable information about the epidemiology of MRSA in a city of the central region of Mexico, and this is the first report on the association between t895 and t9364 spa types and ST5 and ST1011 lineages, respectively. These findings support the importance of permanent surveillance of MRSA aimed to detect the evolutionary changes of the endemic clones and the emergence of new strains.


Sujet(s)
Antibactériens/pharmacologie , Infections communautaires/microbiologie , Infection croisée/microbiologie , Staphylococcus aureus résistant à la méticilline/classification , Typage moléculaire/méthodes , Infections à staphylocoques/épidémiologie , Adolescent , Adulte , Enfant , Enfant d'âge préscolaire , Infections communautaires/épidémiologie , Infection croisée/épidémiologie , Multirésistance bactérienne aux médicaments , Femelle , Humains , Nourrisson , Nouveau-né , Mâle , Staphylococcus aureus résistant à la méticilline/génétique , Staphylococcus aureus résistant à la méticilline/isolement et purification , Mexique/épidémiologie , Tests de sensibilité microbienne , Adulte d'âge moyen , Phylogenèse , Prévalence , Centres de soins tertiaires , Jeune adulte
2.
Toxicol Lett ; 280: 92-98, 2017 Oct 05.
Article de Anglais | MEDLINE | ID: mdl-28823542

RÉSUMÉ

UROtsa cells have been accepted as a model to study carcinogenicity mechanisms of arsenic-associated human bladder cancer. In vitro continuous exposure to monomethylarsonous acid (MMAIII), leads UROtsa cells to commit to malignant transformation. In this process, NF-κß-associated inflammatory response seems to play an important role since this transcription factor activates some minutes after cells are exposed in vitro to MMAIII and keeps activated during the cellular malignant transformation. It is known that a slight decrease in the protein phosphatase and tensin homologue (PTEN) gene expression is enough for some cells to become malignantly transformed. Interestingly, this tumor suppressor has been proven to be negatively regulated by NF-κß through binding to its gene promoter. Based on these observations we propose that NF-κß may be involved in arsenic associated carcinogenesis through the negative regulation of PTEN gene expression. Changes in PTEN expression and the binding of p50 NF-κß subunit to PTEN promoter were evaluated in UROtsa cells exposed for 4, 12, 20, or 24 wk to 50nM MMAIII. Results showed that MMAIII induced a significant decrease in PTEN expression around 20 wk exposure to MMAIII,which correlated with increased binding of p50 subunit to the PTEN promoter. Consistent with these results, ChIP assays also showed a significant decrease in H3 acetylation (H3ac) but an increase in the repression marks H3k9me3 and H327me3 in PTEN promoter when compared with not treated cells. These results suggest that the activation of NF-κß by MMAIII may participate in UROtsa cells malignant transformation through the negative regulation of PTEN expression involving p50 homodimers-mediated chromatin remodeling around the PTEN promoter.


Sujet(s)
Histone/métabolisme , Sous-unité p50 de NF-kappa B/métabolisme , Composés organométalliques/toxicité , Phosphohydrolase PTEN/métabolisme , Lignée cellulaire , Cytokines/génétique , Cytokines/métabolisme , Régulation négative , Régulation de l'expression des gènes/physiologie , Histone/génétique , Humains , Méthylation , Sous-unité p50 de NF-kappa B/génétique , Phosphohydrolase PTEN/génétique , Régions promotrices (génétique)
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE